Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Market Chatter: Pfizer, Moderna Raise COVID-19 Vaccine Prices in EU Supply Contracts

08/01/2021 | 11:51pm EDT


© MT Newswires 2021
All news about PFIZER, INC.
04:01pMODERNA : U.S. administers 383 mln doses of COVID-19 vaccines - CDC
RE
03:20pGOODBYE PFIZER, HELLO COMIRNATY : top COVID-19 vaccines renamed in Canada
AQ
02:35pPFIZER : CEO Backs Booster Shots Ahead of FDA Committee Meeting
MT
01:32pFed's Powell Said to Launch Ethics Review After Regional Presidents Disclose ..
MT
12:40pMODERNA : Pfizer, Biontech Receive Approval From Health Canada for COVID-19 Vacc..
MT
12:01pPFIZER : and BioNTech Covid Vaccine Gets Approval From Health Canada for Individ..
MT
10:38aPFIZER : FDA Sees Current COVID-19 Vaccine Protocol as Still Effective Ahead of ..
MT
10:22aPFIZER : Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (va..
PU
09:06aPFIZER : U.S Provides More Support to Fight Against Covid-19
AQ
07:22aPFIZER : FDA Says Currently Authorized COVID-19 Vaccines in the US Remain Effect..
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 80 759 M - -
Net income 2021 18 248 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,2x
Yield 2021 3,52%
Capitalization 251 B 251 B -
EV / Sales 2021 3,47x
EV / Sales 2022 4,10x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 44,77 $
Average target price 45,02 $
Spread / Average Target 0,56%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.21.46%251 011
JOHNSON & JOHNSON5.11%435 465
ROCHE HOLDING AG11.23%327 497
NOVO NORDISK A/S49.16%231 607
ELI LILLY AND COMPANY38.43%211 895
ABBVIE INC.0.58%190 449